Immunotherapy and RET Lung Cancer
Immunotherapy is a type of treatment that uses the body's own immune system to fight…
Irene Guijarro MunozJuly 8, 2024
What to Ask Your Doctor When Diagnosed with RET-Positive Lung Cancer
Receiving a diagnosis of RET-positive lung cancer can be overwhelming. It's important to ask your…
Irene Guijarro MunozJuly 1, 2024
Resistance: When RET Non-Small Cell Lung Cancer Treatments Stop Working
Cancer drug resistance means that a tumor no longer responds to anticancer drugs that were…
Irene Guijarro MunozJune 24, 2024
American Society of Clinical Oncology Annual Meeting 2024
The 2024 ASCO Annual Meeting, held May 31-June 4 in Chicago, IL, brought together more…
Irene Guijarro MunozJune 18, 2024
Current Treatment Options for RET Lung Cancer
Learn here about the treatment options for patients with RET fusions or other RET alterations,…
Irene Guijarro MunozJune 5, 2024
IASLC Targeted Therapies Recap
#TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…
Irene Guijarro MunozMarch 11, 2024
RET inhibitor Granted Fast Track by FDA
Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by FDA Ellipses Pharma…
Irene Guijarro MunozMarch 11, 2024
The Harmonic™ Clinical Trial for Never Smokers
New clinical trial for never smokers: The Harmonic™ clinical trial The Harmonic™ clinical trial is…
Irene Guijarro MunozMarch 9, 2024
Looking Ahead: The Future of Diagnostic Testing for Patients
Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…
Irene Guijarro MunozJanuary 7, 2024
2023 RET Cancer Research Update
2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…
Irene Guijarro MunozDecember 18, 2023
